Authors
Latest:
Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine SurgeryThe spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.
Latest:
Promising Diagnostic Approaches Emerging for Brain Pathologies: James Leverenz, MDThe director of the Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic discussed new diagnostic techniques that show promise for advancing the understanding of brain pathologies like Alzheimer and Lewy Body diseases. [WATCH TIME: 3 minutes]
Latest:
Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS TechnologyThe professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.
Latest:
Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic HeadacheMia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.
Latest:
Eugenia Trushina, PhD: Communication and Learning Through CollaborationFor the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.
Latest:
Narrowing Down Effective Medications, Classes of Treatments for Migraine: Chia-Chun Chiang, MDThe associate professor of neurology at Mayo Clinic Rochester discussed specific findings from a simultaneous comparison of migraine medications in which certain treatments and classes were more effective. [WATCH TIME: 3 minutes]
Latest:
The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhDThe director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]
Latest:
The Importance of a Globally Aligned, Standardized MRI Protocol for MSLeaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.
Latest:
Pimavanserin Safety Data and Future Research: Clive Ballard, MDClive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.
Latest:
Ari Green, MD, MCR: Remyelination in Multiple SclerosisThe medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.
Latest:
Navigating the Shift from Pediatric to Adult Care Systems in Epilepsy: Danielle Andrade, MD, MSc, FRCPCThe director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the critical issues experienced by patients who transition from pediatric to adult care in epilepsy. [WATCH TIME: 9 minutes]
Latest:
Advancing Multiple Sclerosis Diagnosis With the 2024 Criteria Revision: Xavier Montalban, MD, PhDThe chair of neurology at Hospital Universitari Vall d’Hebron talked about the revision of the MS diagnostic criteria that will integrate new evidence, biological markers, and advanced MRI findings to enable earlier and more precise diagnoses. [WATCH TIME: 4 minutes]
Latest:
Deborah Friedman, MD, MPH: Coordinating Care in TelemedicineThe professor of neurology, neurotherapeutics, and ophthalmology at UT Southwestern discussed the need to better coordinate care between providers when telemedicine is being utilized in headache and migraine care.
Latest:
Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord InjuryThe director of the Center for Spinal Cord Injury Research and co-director of the Spinal Cord Injury Model System Center at Kessler Foundation discussed the secondary medical complications of spinal cord injury and how he and colleagues seek to alleviate them.
Latest:
Treating MS: A Simplified Strategy Boosts Patient and Provider SatisfactionBoth the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.
Latest:
BTKi Treatment ParadigmNeurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.
Latest:
Paul Newhouse, MD: Muscarinic Agonists in Alzheimer TreatmentThe Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.
Latest:
The “Grave Threat” Posed by the Shortage of NeurologistsWith the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.
Latest:
Peii Chen, PhD: Addressing Spatial Neglect After StrokeThe senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.
Latest:
This Week on NeurologyLive® — March 3, 2025Here's some of what is coming soon to NeurologyLive® this week.
Latest:
John Corboy, MD: The DISCO-MS TrialThe professor of neurology at Colorado University spoke about the ongoing phase IV trial to determine the safety of DMT discontinuation in MS.
Latest:
Neurology on the Hill: My Role as an Advocate for NeurologyNeuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.
Latest:
Steve Chung, MD: Cannabidiol in Tuberous Sclerosis ComplexThe neurologist at Banner-University Medicine Neuroscience Institute offered his perspective on data from an open-label safety assessment of cannabidiol (Epidiolex) in the treatment of tuberous sclerosis complex.
